Customer Experience and Design

FDA Wants To Hear About Innovative Technology In Clinical Trials



Over the last decade, the life sciences industry has gone from running clinical trials on paper or, in many cases, in Excel, to leveraging comprehensive web-based systems, such as electronic data capture (EDC) and clinical trial management systems (CTMS). But, in more recent years, the widespread use of mobile technology has enabled even more innovative methods. 

The Digital Essentials, Part 3
The Digital Essentials, Part 3

Developing a robust digital strategy is both a challenge and an opportunity. Part 3 of the Digital Essentials series explores five of the essential technology-driven experiences customers expect, which you may be missing or not fully utilizing.

Get the Guide

Technology affects many different aspects of clinical trials, from helping to recruit and keep patients engaged to capturing clinical and patient data, all the way to managing clinical sites and investigators. With the high costs and long timelines involved with conducting clinical trials, sponsors and clinical research organizations (CROs) are always seeking ways to trim the fat, so to speak. Turns out, the FDA wants a piece of it.

The FDA has issued a Request For Comments regarding the use of technology and other innovative methods in the conduct of clinical trials. Comments are due December 28, 2015.

Click here to read the FDA’s notice.

About the Author

Sr. Marketing Manager, Industries, Perficient

More from this Author

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe to the Weekly Blog Digest:

Sign Up